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Simultaneous effects on 
parvalbumin-positive interneuron 
and dopaminergic system 
development in a transgenic rat 
model for sporadic schizophrenia
Hannah Hamburg1,2,3, Svenja V. Trossbach1, Verian Bader1, Caroline Chwiesko4, Anja Kipar3, 
Magdalena Sauvage4,†, William R. Crum5, Anthony C. Vernon6, Hans J. Bidmon2 & 
Carsten Korth1
To date, unequivocal neuroanatomical features have been demonstrated neither for sporadic nor for 
familial schizophrenia. Here, we investigated the neuroanatomical changes in a transgenic rat model for 
a subset of sporadic chronic mental illness (CMI), which modestly overexpresses human full-length, non-
mutant Disrupted-in-Schizophrenia 1 (DISC1), and for which aberrant dopamine homeostasis consistent 
with some schizophrenia phenotypes has previously been reported. Neuroanatomical analysis revealed 
a reduced density of dopaminergic neurons in the substantia nigra and reduced dopaminergic fibres in 
the striatum. Parvalbumin-positive interneuron occurrence in the somatosensory cortex was shifted 
from layers II/III to V/VI, and the number of calbindin-positive interneurons was slightly decreased. 
Reduced corpus callosum thickness confirmed trend-level observations from in vivo MRI and voxel-wise 
tensor based morphometry. These neuroanatomical changes help explain functional phenotypes of 
this animal model, some of which resemble changes observed in human schizophrenia post mortem 
brain tissues. Our findings also demonstrate how a single molecular factor, DISC1 overexpression or 
misassembly, can account for a variety of seemingly unrelated morphological phenotypes and thus 
provides a possible unifying explanation for similar  findings observed in sporadic schizophrenia patients. 
Our anatomical investigation of a defined model for sporadic mental illness enables a clearer definition 
of neuroanatomical changes associated with subsets of human sporadic schizophrenia.
To date, neuropathological features correlating to the exclusive clinical diagnosis “schizophrenia” are contro-
versial, likely due to 1) the subtlety of changes, 2) the heterogeneity of underlying biological causes, and 3) the 
high inter-subject variability of brain microanatomy in human individuals. Efforts to characterize morphological 
changes have been made since the clinical description of the condition utilizing both in vivo imaging as well as 
post mortem approaches.
Even though the clinical success of dopamine antagonists in treating the acute psychotic phase of schizo-
phrenia in a majority of patients has led to the biological “dopamine hypothesis” of schizophrenia (reviewed in 
ref. 1) and thus helped to define a common ground for this clinical syndrome, neuropathological investigations 
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have failed to clearly define phenotype - clinical disease correlations2–4. This is in contrast to, for example, the 
classification of neurodegenerative diseases, where, apart from distinctive neuronal cell death, each category can 
be defined by the accumulation or disturbed proteostasis of specific proteins. Strikingly, the very same proteins 
that accumulate in the majority of sporadic cases of neurodegenerative diseases are the same as those which are 
mutated in the familial cases that usually make less than 5% of all cases5. Notably, however, any neuropathological 
changes in schizophrenia are likely to be more subtle than those of neurodegenerative diseases and do not com-
prise significant cell death6.
One consistent but unspecific phenotype of schizophrenia patients are enlarged ventricles. For example, a 
recent prospective large-scale meta-analyses of MRI data from more than 2000 cases of schizophrenia and healthy 
controls each via the ENIGMA consortium confirmed an approximate ~19% increase in ventricular volume of 
schizophrenia patients with medium effect size (Cohen’s d = 0.37)7.
Furthermore, a decrease in cortical volume and disproportionate volume loss of temporal structures have 
been described (reviewed in ref. 4). Regarding white matter alterations, the corpus callosum is one of the struc-
tures which most commonly shows abnormalities8,9 with several studies reporting a reduction of its volume10–12.
Early MRI analyses assessing striatal size because of its major dopaminergic input and relevance in cogni-
tive, sensory and motor processing yielded mixed results, with the majority of studies reporting an increase in 
volume (reviewed in ref. 13). Two recent studies have also demonstrated enlarged striatal sizes in drug-naïve 
patients suffering from either schizophrenia or schizotypal disorders14,15. Nevertheless, recent analysis of MRI 
data from the schizophrenia working group of the ENIGMA consortium reported no differences in either cau-
date or putamen volume in schizophrenia patients relative to healthy controls, although increased putamen vol-
umes were associated with duration of illness and age16. This corroborates the findings reported in a large-scale 
meta-analysis of MRI data (18,000 subjects) by Haijma and colleagues17 who observed lower caudate volumes 
only in medication-naïve individuals with schizophrenia compared with controls. Importantly, cumulative expo-
sure to antipsychotic drugs has been linked to either increase or normalization of caudate and putamen volumes, 
as well as cortical thinning in clinical MRI studies of schizophrenia patients17 and pre-clinical MRI studies of 
antipsychotic drug effects on brain volume18,19, making it difficult to always distinguish definitively between drug 
effects and disease effects in medicated schizophrenia patients.
Alterations in the number and positioning of inhibitory GABAergic neurons have repeatedly been reported to 
be a phenotype of schizophrenia (reviewed in refs 20 and 21). The most consistent change is a reduced number of 
interneurons, especially parvalbumin (PV) expressing cells which provide the main inhibitory control for pyram-
idal output neurons (reviewed in ref. 2).
The conundrum is that even though it is generally recognized that schizophrenia comprises heterogeneous 
biological causes converging on a final common, stereotypical behavioural pathway, all cases of schizophrenia are 
still treated as one entity in clinical as well as research practice. This clearly provides the risk of diluting potentially 
different anatomical/neuropathological phenotypes of subsets in investigations under the common umbrella of 
clinically defined “schizophrenia”. In addition, the considerable background of microanatomical inter-subject var-
iability between humans renders investigations of subtle microanatomical changes difficult22,23. It is also not clear 
how the different reported changes could eventually hang together. A solution to this dilemma may be, rather 
than searching for a common denominator to all clinically defined schizophrenia cases, to instead define subsets 
of cases with schizophrenia by common biological and neuropathological signatures from the outset.
Within this context it has been revealing to investigate mutant genes, originally identified in families affected 
with schizophrenia, in genetically modified mouse models. Notably, the mutant Disrupted-in-schizophrenia 1 
(DISC1) gene has been shown to lead to neurodevelopmental changes consistent with the proposed neurode-
velopmental origin of schizophrenia24–26. A mutant DISC1 gene has been identified in two independent families 
to date27–29 and animal models of mutant DISC1 have consistently revealed, amongst other phenotypes, neu-
roanatomical changes including altered interneuron distribution, disturbed dopamine signalling and dendritic 
alterations (reviewed in ref. 30). Furthermore, in utero DISC1 knockdown studies have revealed deficits in the 
migration of pyramidal neurons, a reduced number of PV-interneurons and abnormal maturation of dopamin-
ergic neurons24,31,32 establishing a neurodevelopmental function for DISC1.
DISC1 is known to be involved in the neurodevelopment of cortical progenitor cells via GSK-3β /β -catenin 
where it acts as a switch from proliferation to migration through a phosphorylation site33,34. However, it has 
recently been demonstrated that it is also involved in the tangential migration of cortical interneurons in a regu-
latory manner32. Knockdown of DISC1 leads to a reduction of PV-positive neurons in the cortex by interaction 
with the actin cytoskeleton during nucleokinesis, leading to impaired tangential migration of interneurons origi-
nating from the ganglionic eminence35. Reduced numbers or abnormal distribution of PV-positive neurons are a 
frequent finding in mutant DISC1 mouse models31,36,37.
One characteristic feature of DISC1 mouse models is the enlargement of the lateral ventricles, with some also 
displaying a concurrent thinning of the cortex36–40. Further morphological changes include diverse dendritic 
alterations, such as reduced or enhanced spine density, reduced dendrite length and neurite outgrowth as well as 
mis-oriented dendrites31,36,37,41–43.
To date, partial agenesis of the corpus callosum has been described in one mutant DISC1 mouse model36, 
consistent with the frequent reporting of white matter changes in neuroimaging studies of patients with 
schizophrenia9.
Even though analysis of the effects of mutant genes on neurodevelopment and adult behavioural phenotypes 
may be revealing, potentially linking the mutant gene to a particular disease-related phenotype, it is not evident 
how the non-mutant gene could do so in the majority of sporadic cases of schizophrenia, i.e. patients without 
an obvious genetic defect. One possible way in how non-mutant gene products could nevertheless play a spe-
cific role in disease mechanisms would be through posttranslational modifications. In analogy to the fact that 
proteins subject to proteostatic disturbance in familial cases of neurodegenerative disease are often the same as 
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Figure 1. Dopaminergic fibre density and striosomal surface in the striatum. (A) Schematic figure 
highlighting the relevant anatomical structures of (B) a representative section, bar 1000 μ m. (C) A close-up is 
displayed illustrating the striatum with a dashed line. Grey value and area measurements were obtained within 
this labelled ROI. The position with respect to bregma is indicated in the schematic (lateral) brain illustration, 
bar 250 μ m. (D) Exemplary TH-immunostained striatal sections of each group with the upper specimen 
originating from a tgDISC1 rat and the lower specimen from a littermate control. Colours were inverted to 
www.nature.com/scientificreports/
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those in sporadic cases5, we previously hypothesized that the DISC1 protein could be insoluble in sporadic cases 
of chronic mental illness. Indeed, we demonstrated that to be the case in about 10% of post mortem brains of 
patients with chronic psychiatric disease44. Modelling the presence of insoluble DISC1 aggregates in a transgenic 
rat model by modestly overexpressing the full length, non-mutant DISC1 protein, we observed ubiquitous peri-
nuclear DISC1 aggregates that were accentuated in dopamine-rich regions such as the dorsal striatum, as well as 
biochemical and behavioural phenotypes consistent with aberrant dopamine homeostasis45. Specifically, this rat 
model showed decreased total levels of dopamine in the dorsal striatum, the amygdala and the hippocampus, an 
increased proportion of high-affinity dopamine D2 receptors and translocated dopamine transporter leading to 
altered dopamine flow dynamics. On the systemic level, an amphetamine supersensitivity was also observed45.
Based on this behavioural and neurochemical analysis of the tgDISC1 rat, we hypothesized that morphological 
irregularities in the central nervous system of tgDISC1 rats would be present. We therefore carried out a detailed 
post mortem microscale examination of brains from tgDISC1 rats, as well as littermate controls (LM). Based on 
prior observations in this tgDISC1 rat as well as mutant DISC1 models, this post mortem analysis initially focused 
on the dopaminergic system and PV-interneurons as well as the corpus callosum. In parallel, macroscale MRI 
combined with voxel-wise tensor-based morphometry19 were conducted to provide brain-wide mapping of the 
anatomy of tgDISC1 rats in comparison to LM. Additional post mortem analyses were then carried out guided by 
the additional results arising from the MRI analysis. We found reduced numbers of dopaminergic neurons in the 
compact part of the substantia nigra (SNC) and sparser dopaminergic fibre density in the striatum. The distribu-
tion of PV-positive neurons was shifted to the deeper cortex layers and the corpus callosum showed a volumetric 
decrease in tgDISC1 rats, when compared to LM.
Results
Modest overexpression of full-length human DISC1 reduces TH-positive fibre density in the 
striatum and enlarges the striosomal compartment in tgDISC1 rats. Since we had previously 
observed aberrant dopamine homeostasis in the tgDISC1 rat, accentuated in the striatum45, the histomorphol-
ogy of the striatum of the tgDISC1 rat was analyzed by comparing striatal size and tyrosine hydroxylase (TH)-
positive fibre density of tgDISC1 rats vs. non-transgenic LM (Fig. 1A–C). Grey value for a precise estimation of 
TH-positive fibres as well as area measurements were performed on TH-immunostained brain sections. Analysis 
was carried out on the striatum as a whole and also on both striatal compartments: the matrix and the striosomes.
TgDISC1 rats showed a decrease in grey value intensity following TH immunostaining when compared to LM 
in measurements of the entire striatum (p = 0.005, Cohen’s d = 1.66) as well as in the matrix exclusively without 
the striosomes (p = 0.004, Cohen’s d = 1.73), indicating sparser TH-positive fibres at this location (Fig. 1D–F). 
There was no significant difference in the total area of the striatum, but there was a trend towards an increase 
in transgenic animals (Fig. 1G). Looking at the individual compartments, the size of the striatal matrix did not 
differ between the two groups, whereas a striosomal expansion was present in tgDISC1 rats (p = 0.038, Cohen’s 
d = 1.15, Fig. 1H,I). Therefore, our morphological analysis indicates that tgDISC1 rats display lower TH-positive 
fibre density, resulting from both fewer absolute numbers of TH-positive fibres and enlargement of the striosomal 
compartment.
Decreased numbers of TH-positive neurons in the SNC but not in the VTA of tgDISC1 rats. 
Dopaminergic fibres of the nigrostriatal, mesolimbic and mesocortical pathway arise from neurons in the SNC 
and the ventral tegmental area (VTA), innervating the dorsal striatum as well as the nucleus accumbens and 
cortex, respectively46. To assess potential alterations in dopaminergic neuron density in these regions, we per-
formed a neuronal cell count on TH-immunostained brain sections from both tgDISC1 rats and LM. Transgenic 
animals showed a decrease in TH-positive neurons in the SNC (p = 0.037, Cohen’s d = 1.15) but not in the VTA 
(p = 0.557, Fig. 2). Of note, DISC1 is expressed in the SN as well as the VTA (Supplementary Figure 1).
Dopamine fibre density in the amygdala is not affected by DISC1 overexpression. The amyg-
dala plays a major role in processing affective and especially threatening stimuli as well as emotional memory 
consolidation. It receives its dopaminergic input from the VTA. To determine whether changes in dopamine 
fibre density, such as those observed in the striatum, were also present in the amygdala, we examined the size 
and TH-positive fibre density within the amygdalar complex (Fig. 3A–C). The amygdala was divided into lateral, 
basal, and central nuclei.
better illustrate the fibre density, and close-ups are displayed on the right. Note the subtly sparser matrix and 
increase of striosomal surface in the tgDISC1 rat. Bars 250 μ m. (E) Grey value of the entire striatum. TgDISC1 
rats display lower grey intensity in the entire striatum (p = 0.005). (F) Grey value of the striatal matrix without 
striosomes. TgDISC1 rats have a lower grey intensity in the striatal matrix (p = 0.004). (G) Area of the entire 
striatum including matrix and striosomal compartment. No difference in the surface area is detected between 
the two groups. (H) Area of the striatal matrix. No difference in the surface area of the striatal matrix is detected 
between the two groups. (I) Area of striosomes. TgDISC1 rats have an increased striosomal area (p = 0.038). 
(J) Magnification of the dorsal striatum of a LM on the left and a tgDISC1 rat on the right, note the sparser 
PV-positive interneurons in the tgDISC1 rat, bar 250 μ m. (K) PV-positive interneurons in the dorsal striatum. 
PV-interneuron number is decreased in tgDISC1 rats (p = 0.047). Surface area is displayed in μ m2 ± s.e.m. 
and normalized reciprocals of the grey values are displayed in percent ± s.e.m. Abbreviations: anterior part of 
the anterior commissure (aca), cortex (C), corpus callosum (cc), external capsule (ec), striatum (St), olfactory 
tubercle (Tu).
www.nature.com/scientificreports/
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Figure 2. Tyrosine Hydroxylase-positive neurons in the substantia nigra pars compacta and the 
ventral tegmental area. (A) Schematic figure highlighting the relevant anatomical structures of a (B) TH-
immunostained exemplary section, bar 1000 μ m. (C) A close-up of these nuclei is displayed, bar 250 μ m. The 
position with respect to bregma is indicated in the lateral schematic illustration. (D) Magnification of the SN 
of a tgDISC1 rat on the left and a LM on the right with magnifications displayed in the centre. Note the sparser 
TH-positive neurons in the SN of the tgDISC1 rat. Bars are 250 μ m. (E) TH-positive neurons in the SNC. 
TgDISC1 rats have a decreased number of TH-positive neurons in the SNC (p = 0.037) compared to littermate 
controls. (F) TH-positive neurons in the VTA. No difference in quantity of TH-positive neurons is observed 
in the VTA (p = 0.557). Neuronal cell counts are displayed in number of cells ± s.e.m. Abbreviations: cortex 
(C), cerebral peduncule (cp), hippocampus (H), medial terminal nucleus of the accessory optical tract (MT), 
substantia nigra, pars compacta (SNC), substantia nigra, pars reticulate (SNR), ventral tegmental area (VTA).
www.nature.com/scientificreports/
6Scientific RepoRts | 6:34946 | DOI: 10.1038/srep34946
Grey value measurement showed no differences between tgDISC1 rats and LM (Fig. 3D–F). However, 
tgDISC1 rats displayed a slight but non-significant trend towards an increased size of the basal nucleus and a 
trend towards a slight shrinkage of the central nucleus (Supplementary Figure 2).
Altered PV-interneuron distribution in the cortex, but no differences in cortical layer thickness 
in the tgDISC1 rat. To determine whether DISC1 overexpression causes alterations in quantity or distribu-
tion of immunolabelled interneurons, we examined cortical layer thickness as well as Glutamate Decarboxylase 
67 (GAD67), PV- and calbindin (CB)-positive interneuron numbers and distribution in tgDISC1 rats compared 
to LM (Fig. 4A–C). Analysis was performed in the primary somatosensory cortex (S1), specifically in both the 
forelimb region (S1FL) and the barrel field (S1BF). Of note, changes in interneuron frequency in the somatosen-
sory cortex have been reported in CMI patients47–50. Numbers of interneurons in both groups were compared 
in each cortical layer as well as the total cell count across all such layers. For the assessment of cortical thick-
ness, adjacent Nissl stained sections were used which is the gold standard method for determining cortical lay-
ers in adult animal brains51–53. No differences in the cortical thickness were observed between the two groups 
(Supplementary Figure 3).
In tgDISC1 rats, numbers of PV-positive interneurons were decreased in layers II+ III (p = 0.005, Cohen’s 
d = 1.72) and increased in layers V (p = 0.011, Cohen’s d = 1.56) and VI (p = 0.019, Cohen’s d = 1.69), thus reveal-
ing a modified distribution pattern (Fig. 4D–H). This shift of PV-positive interneurons to deeper cortical layers 
was present in both S1BF as well as in the S1FL region, being more pronounced in the S1BF. However, no changes 
in the total number of PV-positive interneurons were observed (p = 0.963 in the S1FL and p = 0.732 in the S1BF, 
Fig. 4F,H).
Figure 3. Dopaminergic fibre density in the amygdala. (A) Schematic figure highlighting the relevant 
anatomical structures of (B) a TH-immunostained exemplary section, bar 1000 μ m. (C) A close-up is displayed 
illustrating the amygdalar nuclei with a dashed line. Grey value and area measurements were carried out in 
the lateral, the basal and the central nucleus. The position with respect to bregma is indicated in the lateral 
schematic illustration, bar 250 μ m. (D–F) Grey value of the lateral, basal and central nucleus, respectively. No 
differences in grey value of the nuclei of the amygdala are detected between the two groups. The normalized 
reciprocals of the grey value are displayed in percent ± s.e.m. Abbreviations: amygdalostriatal transition area 
(ASt), basal amygdalar nucleus (BA), cortex (C), corpus callosum (cc), central amygdalar nucleus (CeA), 
external capsule (ec), dorsal endopiriform nucleus (DEn), Hippocampus (H), lateral amygdalar nucleus (LA), 
piriform cortex (Pir), striatum (S).
www.nature.com/scientificreports/
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Figure 4. Distribution of Parvalbumin (PV)-positive interneurons in the SSC and cortex layer thickness. 
(A) Schematic figure highlighting the relevant anatomical structure of (B) a PV-immunostained exemplary 
section, bar 1000 μ m. (C) A close-up of a ROI of the barrel field is illustrated, bar 250 μ m. ROIs of 500 μ m 
width and variable length covering all cortical layers were placed perpendicularly to the white matter and 
interneurons were counted per cortex layer. The position with respect to bregma is indicated in the lateral 
schematic illustration. (D). ROIs from the barrel field of a LM (left panel) and a tgDISC1 rat (right panel) 
www.nature.com/scientificreports/
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CB-positive interneurons had similar distribution patterns in both tgDISC1 rats and LM, however, their total 
amount was slightly decreased in the S1BF but not in the S1FL of tgDISC1 rats (Supplementary Figure 4). No 
changes were observed in GAD67-positive interneurons (Supplementary Figure 5), indicating that DISC1 targets 
only a subpopulation of (PV positive) interneurons.
Reduced PV-interneurons in the dorsal striatum, but no differences in the hippocampus of 
tgDISC1 rats. Considering the changes in the dopaminergic projections in the striatum and the aberrant 
distribution of PV-interneurons, we addressed neuron numbers of PV- and GAD67-interneurons in the striatum. 
PV-interneurons were significantly reduced in the dorsal striatum (p = 0.047, Cohen’s d = 1.4, Fig. 1J,K), unlike 
GAD67-interneurons that were not affected (Supplementary Figure 5). In the hippocampus, neither group of 
interneurons was significantly altered, even though there was a trend (p = 0.067) to decreased interneurons in 
layer in the CA1 subfield of the hippocampus (Supplementary Figure 6).
Macroscale neuroanatomy of tgDISC1 rats in comparison to LM. We utilized MR images from 
live, anaesthized tgDISC1 rats (n = 21) and LM (n = 24) for automated, voxel-wise, tensor-based morphometry 
(TBM) analysis to examine neuroanatomical differences on a brain-wide scale. This analysis revealed no signifi-
cant clusters of volume increase or decrease when comparing tgDISC1 rats and LM after FDR correction (q = 0.1), 
irrespective of controlling for variation in brain volume (Fig. 5A,B). We therefore conducted a second-level anal-
ysis at an exploratory threshold of p < 0.05 (uncorrected for multiple comparisons). This revealed left-lateralized 
trend-level decreases in the volume of the corpus callosum and external capsule (Fig. 5A). These remain, although 
to a reduced extent, when analysis was performed taking into account the variation in whole brain volume 
(Fig. 5B). The latter analysis also revealed an additional left-lateralized cluster of voxels of increased volume in the 
hippocampus, particularly, the CA3 sub-field (Fig. 5B). Consistent with the MRI investigations outlined above 
there were no significant changes in the volume of the cortex when comparing tgDISC1 rats and LM.
Increased hippocampal volume and decreased corpus callosum volume in tgDISC1 rats. 
Despite the high power, the TBM analysis findings did not survive statistical correction for multiple comparisons. 
This may in part be due to the anisotropic 2D nature and low resolution of the MR images acquired, which may 
affect the precision of our image registration and negatively affect our ability to detect subtle anatomical differ-
ences between groups using TBM54,55. Nevertheless, TBM demonstrated clear trends that might be regarded as 
“hypothesis generators” to guide further focused postmortem investigations, not based on any a priori hypoth-
eses19. Therefore, to evaluate the changes in the corpus callosum observed by NMR imaging at a finer scale, we 
calculated volume estimations using Cavalieri’s principle56,57 to confirm (or disprove) the trend suggested by the 
imaging findings. Our calculations confirmed a volumetric reduction of the corpus callosum (p = 0.013, Cohen’s 
d = 1.3). We could also confirm a slight increase in hippocampal volume of tgDISC1 rats (p = 0.042, Conhen’s 
d = 1.3). Due to the fact that TBM results were available after histological preparation of the brains, section sam-
pling of the hippocampus did only partially allow an unequivocal comparison between animals. Therefore, we 
rather consider this as a supporting trend.
Discussion
DISC1 is a major vulnerability factor for a wide range of chronic mental illnesses6,58–60, including schizophrenia, 
but without a clear segregation to a specific clinical diagnosis. We generated the tgDISC1 rat as a model for  a 
subset of sporadic chronic mental illnesses, in contrast to existing mouse models which variously investigate the 
Scottish mutation, artificial mutations or partial knockouts of Disc1 (reviewed in ref. 30). The tgDISC1 rat dis-
plays protein pathology which is of relevance for sporadic cases of mental illnesses and has a distinct phenotype 
of aberrant dopamine homeostasis45. In this study, we report morphological aberrations in the tgDISC1 rat, both 
at light microscopical level and macroscale (MRI).
Our analyses revealed a decrease in dopaminergic neurons in the SNC, reduced fibre density in the striatum, 
and an increase in striosomal surface area. This is consistent with our previous finding of reduced whole dopa-
mine content in the dorsal striatum45. Dopaminergic neurons from the SNC send their neurites to the striatum, 
forming the nigrostriatal pathway46. Both this decrease and an increased striosomal surface area seem to be rele-
vant factors leading to a reduced dopaminergic fibre density in the striatum. Imbalances between the striosomal 
compartment and the matrix have been reported to play a role in various neurological disorders, in which they 
with magnifications in the centre. Note the reduced PV-interneuron number in layers II/III and its increase 
in layers V/VI, bars 250 μ m. (E) Cortex thickness including all layers. No difference between the two groups 
is detected in the thickness of the entire cortex. (F) PV-positive neurons per cortex layer in the BF. TgDISC1 
rats show a decrease of PV-positive neurons in layer II+ III (p = 0.005) and an increase in layers V (p = 0.011) 
and VI (p = 0.019) compared to littermate controls. (G) Total cell count of PV-positive neurons in the BF. No 
difference in total number of PV-positive neurons is detected. (H) PV-positive neurons per cortex layer in the 
FL region. In tgDISC1 rats, PV-positive neurons are reduced in layer II + III (p = 0.014), but increased in layers 
V (p = 0.022) and VI (p = 0.015). (I) Total cell count of PV-positive neurons in the FL region. No difference 
in total number of PV-positive neurons is detected. Layer thickness is displayed in μ m ± s.e.m., neuronal cell 
counts are displayed in number of cells ± s.e.m. Abbreviations: amygdala (Am), corpus callosum (cc), external 
capsule (ec), hippocampus (H), insular cortex (I), lateral ventricle (LV), motor cortex (M), piriform cortex 
(Pir), retrosplenial cortex (RS), barrel field of the primary somatosensory cortex (S1BF), dysgranular zone of 
the primary somatosensory cortex (S1DZ), trunk region of the primary somatosensory cortex (S1Tr), upper lip 
region of the primary somatosensory cortex (S1ULp), secondary somatosensory cortex (S2).
www.nature.com/scientificreports/
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are believed to be a causal factor of mood dysfunctions61. Interference of DISC1 with the development of the 
dopaminergic system has been demonstrated in various DISC1 mouse models using neurochemistry, biochemis-
try and behavioural tests (reviewed in ref. 30), however, to the best of our knowledge, in none of these models has 
a detailed neuroanatomical analysis been performed. Thus we conclude that DISC1 is involved in the develop-
ment of a mature dopaminergic system and its overexpression and misassembly leads to structural abnormalities 
in the nigrostriatal pathway in the tgDISC1 rat. At this point, we cannot explain why in the tgDISC1 rat only the 
SN but not the VTA is affected even though both nuclei stain positive for DISC1 (Figure S1), but the differential 
effect may hint that additional molecular factors are required for DISC1 to exert the described effect, and that 
these are differentially present in the SN and the VTA.
Aberrations of interneurons have been reported in several mutant DISC1 mouse models31,36,37, with a reduced 
number of PV-positive interneurons being the most frequently reported abnormality (reviewed in ref. 30, see also 
Table 1). Indeed, tgDISC1 rats also show differences when compared to LM. We conducted our analyses in the 
primary somatosensory cortex as it is a commonly affected site in schizophrenia and recent research emphasised 
that alterations of this region are specific to schizophrenia47. The distribution of PV-interneurons is shifted to 
the deeper layers in tgDISC1 rats in both the S1BF and the S1FL. Since the thickness of the cortical layers does 
not change, the abnormal localization pattern is likely the consequence of a migration deficit, as opposed to a 
layer displacement. The possibility of a mutual relationship existing between altered cortical PV-positive neu-
ronal distribution patterns and alterations in the dopaminergic system cannot be excluded. Furthermore, the 
PV-interneuron number in the dorsal striatum is reduced.
We did not find significant changes when staining for GAD67 was performed (Supplementary Figure 5) which 
contrasts to the consistent and positive findings for PV positive interneurons in S1 and the dorsal striatum. For 
rodents, it has been described that only 40% of GAD67 positive interneurons are also PV positive62 meaning that 
Figure 5. Neuroanatomical differences between LM and tgDISC1 rats assessed through TBM. Maps of 
voxel-wise local volumetric changes expressed as the delta log scaled jacobian determinant (Δ log J) in male 
tgDISC1 rats (n = 21) compared to LM (NC; n = 24) at 6 months of age. Images are presented as either (A) 
global volume change (6 dof), or (B) absolute changes corrected for global changes (9 dof). Colour scales 
are for volume difference (cyan/blue to red/yellow) and the raw t statistical value at each voxel (dark to light 
green). Data shown are raw values of Δ log J and their associated t-statistic at each voxel and following statistical 
comparisons at both p < 0.05 uncorrected and following corrections for multiple comparisons (FDR = q < 0.1).
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any significant effect in this subpopulation would be diluted out if DISC1 was specific and not a general regulator 
of interneuron migration, which, as our data show, is not the case. DISC1 overexpression thus specifically affects 
PV neuron migration. In this context, it is interesting to note that the dominant negative Shen et al. mouse36 
has opposite changes in PV positioning thus setting the dominant negative and overexpressing phenotypes in 
opposition.
Our observations resemble findings of post mortem studies on brains of sporadic schizophrenia patients which 
consistently reported alterations in GABAergic interneurons. Typically, PV-interneurons are reduced in the mid-
dle layers of the cortex, resulting in disturbed microcircuitry63,64. The reduced PV-interneuron density in the 
middle layers demonstrated in tgDISC1 rats may potentially have similar effects, resulting in a discrepancy of 
the most important inhibitory input to pyramidal effector neurons in layers II/III. In contrast, CB-interneurons 
do not display such prominent changes, with their total number being slightly decreased in the BF. Looking at 
each individual cortex layer, a very subtle reduction can nevertheless be noted resulting in a discretely declined 
total cell count. Of note, dopaminergic receptors seem to be selective for PV-interneurons, which could partially 
explain the more striking abnormalities in that interneuron subgroup65.
Our findings here, for technical reasons, focus on changes in the S1 (somatosensory cortex). Even though 
many investigations in humans report changes in the prefrontal cortex, recent functional imaging data comparing 
patients suffering from depression or schizophrenia identified S1 as cortical subdivision specifically affected in 
schizophrenia whereas prefrontal cortex and cuneus were affected in both groups of patients47. This highlights 
that on the neuroanatomical level, the somatosensory cortex has been neglected and our data may encourage 
more neuroanatomical investigations in that area.
TgDISC1 rats have previously been reported to have enlarged lateral ventricles, based on a blinded manual 
analysis45. These findings are consistent with observations in schizophrenia: ventricular enlargement is a common 
morphological feature of schizophrenia, while a reduction of the corpus callosum has also been reported in sev-
eral studies (reviewed in refs 8 and 9). The absence of significance changes in layer thickness makes a significant 
decrease in layer II/III efferent fibres unlikely and thus sets into focus the possibility of primary changes of white 
matter. Indeed, in an in vitro model, it was suggested that DISC1 has a negative regulatory effect on oligodendro-
cyte differentiation: DISC1 overexpression impeded their outgrowth, whereas a knockdown promoted it66. These 
in vitro findings would be consistent with our in vivo findings.
Furthermore, operator-independent, brain-wide TBM analysis of tgDISC1 rats suggests a trend-level reduc-
tion in the volume of the corpus callosum and the external capsule, which we could confirm in our subsequent 
volumetric measurement on a microscopic scale. Indeed, the enlargement of lateral ventricles and the volume of 
the corpus callosum are mutually dependent variables since an inverse correlation between the volumes of these 
structures has been recently demonstrated in an MRI study of schizophrenia patients67.
In summary, the tgDISC1 rat displays morphological changes in several areas of the brain, including in 
dopaminergic cells and projections, cortical interneuron positioning and white matter/ventricle volume. While 
some findings are common among schizophrenia models, morphological changes of dopaminergic cells and 
Morphological Characteristics of DISC1 models
Ventricles Cortex TH PV CB GAD67 CC Hipp
mDisc1(∆ 2–3)
Kuroda et al. 2011 = = = 
Nakai et al. 2014 = = 
Umeda et al. 2016 ↓ ↓ 
mDisc1(129S6/SvEv)
Koike et al. 2006 = = 
Kvajo et al. 2008 = = 
Juan et al. 2014 ↑ = = 
mDisc1(∆ 9–13) Shen et al. 2008 ↑ ↓ ↓ *, ↑ **, = ***, ↓ Hipp ↓ 
hDISC1(1–597)
Hikida et al. 2007 ↑ ↓ = 
Ibi et al. 2010 = 
inducible-hDISC1(1–597)
Pletnikov et al. 2008 ↑ 
Ayhan et al. 2010 ↑ ↓ ↓ 
Abazyan et al. 2010 ↑ 
mDisc1-Q31L
Clapcote et al. 2007 ↓ 
Chandran et al. 2014 = 
Borkowska et al. 2016 = 
mDisc1-L100P
Clapcote et al. 2007 ↓ 
Chandran et al. 2014 ↓ GD
Borowska et al. 2016 ↓ = 
tgDISC1 rat
Trossbach et al. 2016 ↑ 
this manuscript = ↓ ↑ *, ↓ **, = ***, ↓ St ↓ *** = ↓ ↑ 
Table 1.  Morphological characteristics of DISC1 animal models. The table summarizes relevant 
morphological characteristics of DISC1 animal models. Abbreviations: *inner layers, **outer layers, ***total, 
CC = corpus callosum, GD = gyrus dentatus, Hipp = hippocampus, St = striatum.
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PV-interneurons in the tgDISC1 rat seem to be unique among present animal models (Table 1), presumably due 
to its distinguishing feature of human full-length DISC1 overexpression.
To various extents, similar findings also have been reported in neuroanatomical investigations in post 
mortem brains of patients with schizophrenia. The present results also allow to establish a causal relationship 
between DISC1 overexpression/misassembly and a variety of seemingly unrelated morphological phenotypes, 
i.e. decreased dopaminergic cells and fibres, PV-positive interneurons, enlarged ventricles and decreased white 
matter in the corpus callosum. It is thus conceivable that a single molecular cause can simultaneously be linked to 
these morphological findings that, in part, have also been reported in patients with schizophrenia. We conclude 
that the tgDISC1 rat is therefore a face valid animal model for a subset of sporadic schizophrenia, based not only 
on the described behavioural and physiological phenotype of aberrant dopamine homeostasis but also in terms 
of its neuroanatomical phenotype.
Materials and Methods
Animals. All experiments were conducted in conformity with the Animal Protection Law and were approved 
by local authorities (LANUV NRW, Recklinghausen, Germany). Male Sprague-Dawley rats were housed under 
12 h light/dark conditions with ad libitum access to food and water.
Magnetic resonance imaging. Structural MRI analysis was performed as previously described45 on a 7.0 
tesla small animal Scanner (Bruker BioSpin, Billerica, MA, USA) with a horizontal bore magnet. We utilized 
voxel-wise tensor based morphometry (TBM) on coronal scans from tgDISC1 rats (n = 21) and LM (n = 24) to 
provide an unbiased, brain-wide overview of neuroanatomical differences between tgDISC1 rats and LM. TBM 
analysis was performed as previously described19,68,69. Briefly, all brains in the study were first rigidly aligned 
using an automated intensity-based group-wise registration approach70,71. A high-dimensional non-rigid reg-
istration algorithm was applied to warp each globally aligned scan to the population refs 70,72 and 73. Maps 
of localized volume difference at each voxel relative to the reference brain were computed from the log of the 
Jacobian determinant of this non-rigid transformation for each scan. Voxel-wise statistical tests over a brain mask 
were performed to establish regions of significant volumetric difference between groups. These analyses were 
performed for both absolute (6 degrees of freedom [dof] registration) and relative (9 dof registration) changes in 
volume, the latter taking into account population variation in anatomy due to differences in total brain volume54. 
Voxel-wise analyses were corrected for multiple comparisons using the false discovery rate (FDR) correction74 
at a threshold of q = 0.1 (10%)55. Additional exploratory analyses were performed at p < 0.05, uncorrected for 
multiple comparisons.
Tissue preparation. Fourteen tgDISC1 rats and fourteen LM aged four to five months were deeply anes-
thetized with sodium-pentobarbital (70 mg/kg) and transcardially perfused with saline and heparin (400 ml, 
10000 IU/l) followed by Zamboni fixative (400 ml, 4% paraformaldehyde and 10% picric acid in PBS, pH 7.4).
Brains were removed and post-fixed in Zamboni fixative for 48 h and incubated in sucrose solution (30% in 
PBS, pH 7.4) over a period of 48 h for cryoprotection. Subsequently, brains were frozen in isopentane at − 40 °C 
and stored at − 80 °C before further processing.
Frozen coronal sections of 50 μ m thickness were cut using a microtome cryostat system (Leica SM2000R, 
Leica Biosystems, Wetzlar, Germany).
For Nissl staining, sections were mounted on tissue slides, air dried, and immersed in 70% ethanol for 12 h. 
Treatment with 0.1% cresyl violet solution (Sigma-Aldrich, St. Louis, MO, USA) for 20 min was followed by dif-
ferentiation in 70% ethanol for 10 min. Then, sections were dehydrated in ascending series of ethanol (70% for 
10 min, 96% for 20 min and 100% for 30 min), treated with xylene (100%, twice for 10 min each) and covered with 
coverslips using DPX Mounting medium (Sigma-Aldrich, St. Louis, MO, USA).
Free floating immunohistochemical staining for each marker was carried out in multiwell plates in parallel on 
tissue sections from all animals.
Sections were initially incubated in blocking solution (10% normal goat serum, Vector laboratories, 
Burlingame, CA, USA, S-1000 and 0.3% saponin in PBS, pH 7.4) for 2 h at room temperature to reduce 
non-specific background staining. This was followed by incubation with the primary antibodies diluted in 
2% normal goat serum and 0.1% saponin in PBS for 48 h at 4 °C. Anti-tyrosine-hydroxylase-antibody (1:100, 
mouse-monoclonal, Millipore, Billerica, MA, USA, MAB318), anti-GAD67-antibody (1:500, mouse-monoclonal, 
Millipore, Billerica, MA, USA, MAB5406), anti-parvalbumin-antibody (1:10.000, mouse-monoclonal, 
Sigma-Aldrich, St. Louis, MO, USA, P-3171) and anti-calbindin-antibody (1:10.000, mouse-monoclonal, 
Sigma-Aldrich, C-9848) were used as primary antibodies. Rinsing in PBS (pH 7.4) was carried out three times 
for 30 min. Biotinylated secondary anti-mouse antibodies (1:500, Dianova, Hamburg, Germany, 115-065-166) 
diluted in PBS (pH 7.4) were used as secondary antibodies and sections incubated for 24 h at 4 °C, then rinsed in 
PBS (pH 7.4) three times for 15 min.
Sections were incubated with ABC reagent for 30 min at room temperature (ABC elite kit, 1:300, Vector labo-
ratories, Burlingame, CA, USA, PK-6100) and washed out for 15 min using PBS (pH 7.4), followed by incubation 
with trisamine buffer twice for 15 min (pH 8.1, 0.05 M, Trizma® base, Sigma-Aldrich, T1503).
Sections were incubated with diaminobenzidine (DAB) (0.05% DAB in trisamine buffer, pH 7.6) for 10 min 
and hydrogen peroxide (1% H2O2, resulting in a final concentration of 0.01% H2O2 in the probes) was added for 
precisely 10 minutes to all sections. Afterwards the sections were rinsed three times in trisamine buffer (pH 7.6). 
Finally they were mounted on adhesive glass slides (HistoBondR, P. Marienfeld, Lauda-Königshofen, Germany) 
and covered with coverslips using DPX Mounting medium (Sigma-Aldrich, St. Louis, MO, USA).
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Tissue analysis. Anatomical regions were defined according to The Rat Brain in Stereotaxic Coordinates by 
Paxinos and Watson75. Specimens were digitalized at a resolution of 0.01 μ m/pixel using a Zeiss Axio Z1 imager 
and Zen software (Zeiss, Jena, Germany). Tissue samples were blinded and randomized.
For the analysis of the dopamine pathway, equidistant brain slices of eight animals were used per group. 
Seven striatal sections between bregma 2.5 and − 1.0 mm, six sections of the amygdala between bregma − 2.0 and 
− 3.2 mm, ten sections of the SNC between bregma − 4.8 and − 5.8 mm, and eight sections of the VTA between 
bregma − 5.2 and − 6.0 mm were analysed per animal.
Digitalized specimens were converted to 8-bit grey value images using IrfanView (Irfan Skiljan, Vienna, 
Austria).
The striatal region was digitally defined and the mean grey value and the area were measured using a script of 
Matlab software (MathWorks, Natick, MA, USA). In order to measure the mean grey value of the striatal matrix 
exclusively, a threshold of 120 was defined, resulting in the subtraction of the striosomes.
The amygdala was divided into basal, lateral and central nuclei and the mean grey value and area were meas-
ured using the above mentioned Matlab script (MathWorks, Natick, MA, USA).
Normalized reciprocals of the grey values are displayed in the charts in order to clarify the correlation between 
measured grey value and fibre density.
Neuronal cell count in the SNC and the VTA was performed using the multi-point tool in ImageJ (National 
Institute of Health, Methesda, MD, USA).
For the analysis of GAD67-, CB- and PV-positive interneurons, six animals were used per group. Analysis was 
performed in the forelimb region (S1FL) and the barrel field (S1BF) of the primary somatosensory cortex (S1) 
using eight equidistant sections per neuronal marker and anatomical region between bregma 1.2 and − 0.2 and 
bregma − 0.8 and − 3.7, respectively.
A region of interest of 500 μ m width and variable length comprising all cortical layers was set perpendicular to 
the white matter at random positions within the above-mentioned anatomical locations. Neurons were counted 
per cortex layer using the multi-point-tool in ImageJ (National Institute of Health, Methesda, MD, USA).
The thickness of the cortical layers was measured on consecutive Nissl stained sections perpendicularly to the 
white matter using ImageJ (National Institute of Health, Methesda, MD, USA).
PV- and GAD67-positive interneurons in the dorsal striatum were counted in three sections per animal from 
bregma 1.2, 0.6 and 0.0 in a region of interest of 1 mm2 and in two sections of the anterior hippocampus (bregma 
− 3.0 and − 4.0). The hippocampus was devided in its subregions CA1, CA3 and gyrus dentatus. The cell count 
was performed as described above.
Volumes of the CC and the anterior hippocampus were estimated using the Cavalieri’s principle on 
PV-immunostained slides of six animals per group56,57. Stereological analyses was performed on four sections 
per animal from bregma 2.0, 0.5, − 1.0, and − 2.5, in the CC and two sections per animal from bregma 2.7 and 3.6 
in the hippocampus. A stereological counting grid was placed over the specimens and volumes were calculated 
from Cavalieri’s principle:
∑= × ×V t a p P( ) (1)hip hip
∑= × ×V t a p P( ) (2)CC CC
in which Vhip and VCC are the volumes of the hippocampus and the CC, t is the slice thickness, a(p) the area asso-
ciated with each point in the grid and Σ Phip and Σ PCC are the total number of points hitting the hippocampus and 
the CC, respectively.
Statistical analysis. All data were tested for normal distribution using D’Agostino-Pearson omnibus nor-
mality test and Kolmogorov-Smirnov normality test and two-tailed unpaired t-test was applied. Statistical analy-
sis was performed using GraphPad Prism 6 software (GraphPad, La Jolla, CA, USA).
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